Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 227

1.

Dissecting molecular mechanisms of resistance to Notch1-targeted therapy in T-cell acute lymphoblastic leukemia xenografts.

Agnusdei V, Minuzzo S, Pinazza M, Gasparini A, Pezzè L, Amaro AA, Pasqualini L, Del Bianco P, Tognon M, Frasson C, Palumbo P, Ciribilli Y, Pfeffer U, Carella M, Amadori A, Indraccolo S.

Haematologica. 2019 Aug 29. pii: haematol.2019.217687. doi: 10.3324/haematol.2019.217687. [Epub ahead of print]

2.

Silencing of miR-182 is associated with modulation of tumorigenesis through apoptosis induction in an experimental model of colorectal cancer.

Perilli L, Tessarollo S, Albertoni L, Curtarello M, Pastò A, Brunetti E, Fassan M, Rugge M, Indraccolo S, Amadori A, Bortoluzzi S, Zanovello P.

BMC Cancer. 2019 Aug 20;19(1):821. doi: 10.1186/s12885-019-5982-9.

3.

A juxtacrine/paracrine loop between C-Kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancer.

Mazzoldi EL, Pavan S, Pilotto G, Leone K, Pagotto A, Frezzini S, Nicoletto MO, Amadori A, Pastò A.

Cell Death Dis. 2019 May 28;10(6):412. doi: 10.1038/s41419-019-1656-4.

4.

Immune System and DNA Repair Defects in Ovarian Cancer: Implications for Locoregional Approaches.

Farolfi A, Gurioli G, Fugazzola P, Burgio SL, Casanova C, Ravaglia G, Altavilla A, Costantini M, Amadori A, Framarini M, Ansaloni L, De Giorgi U.

Int J Mol Sci. 2019 May 25;20(10). pii: E2569. doi: 10.3390/ijms20102569. Review.

5.

Cell membrane protein functionalization of nanoparticles as a new tumor-targeting strategy.

Pasto A, Giordano F, Evangelopoulos M, Amadori A, Tasciotti E.

Clin Transl Med. 2019 Mar 15;8(1):8. doi: 10.1186/s40169-019-0224-y. Review.

6.

Association Between ERCC1 rs3212986 and ERCC2/XPD rs1799793 and OS in Patients With Advanced Esophageal Cancer.

Boldrin E, Malacrida S, Rumiato E, Battaglia G, Ruol A, Amadori A, Saggioro D.

Front Oncol. 2019 Feb 21;9:85. doi: 10.3389/fonc.2019.00085. eCollection 2019.

7.

Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer.

Conteduca V, Gurioli G, Rossi L, Scarpi E, Lolli C, Schepisi G, Farolfi A, De Lisi D, Gallà V, Burgio SL, Menna C, Amadori A, Losi L, Amadori D, Costi MP, De Giorgi U.

BMC Cancer. 2018 Dec 19;18(1):1267. doi: 10.1186/s12885-018-5180-1.

8.

A Novel t(8;14)(q24;q11) Rearranged Human Cell Line as a Model for Mechanistic and Drug Discovery Studies of NOTCH1-Independent Human T-Cell Leukemia.

Tosello V, Milani G, Martines A, Macri N, Van Loocke W, Matthijssens F, Buldini B, Minuzzo S, Bongiovanni D, Schumacher RF, Amadori A, Van Vlierberghe P, Piovan E.

Cells. 2018 Oct 9;7(10). pii: E160. doi: 10.3390/cells7100160.

9.

A Preclinical Model for the ATLL Lymphoma Subtype With Insights Into the Role of Microenvironment in HTLV-1-Mediated Lymphomagenesis.

Vicario M, Mattiolo A, Montini B, Piano MA, Cavallari I, Amadori A, Chieco-Bianchi L, Calabrò ML.

Front Microbiol. 2018 Jun 13;9:1215. doi: 10.3389/fmicb.2018.01215. eCollection 2018.

10.

Chemotactic Cues for NOTCH1-Dependent Leukemia.

Piovan E, Tosello V, Amadori A, Zanovello P.

Front Immunol. 2018 Apr 3;9:633. doi: 10.3389/fimmu.2018.00633. eCollection 2018. Review.

11.

Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells.

Pinazza M, Ghisi M, Minuzzo S, Agnusdei V, Fossati G, Ciminale V, Pezzè L, Ciribilli Y, Pilotto G, Venturoli C, Amadori A, Indraccolo S.

Oncogene. 2018 Jul;37(28):3839-3851. doi: 10.1038/s41388-018-0234-z. Epub 2018 Apr 12.

12.

WT1 loss attenuates the TP53-induced DNA damage response in T-cell acute lymphoblastic leukemia.

Bordin F, Piovan E, Masiero E, Ambesi-Impiombato A, Minuzzo S, Bertorelle R, Sacchetto V, Pilotto G, Basso G, Zanovello P, Amadori A, Tosello V.

Haematologica. 2018 Feb;103(2):266-277. doi: 10.3324/haematol.2017.170431. Epub 2017 Nov 23.

13.

Detection of genetic alterations in cfDNA as a possible strategy to monitor the neoplastic progression of Barrett's esophagus.

Rumiato E, Boldrin E, Malacrida S, Realdon S, Fassan M, Morbin T, Battaglia G, Amadori A, Rugge M, Saggioro D.

Transl Res. 2017 Dec;190:16-24.e1. doi: 10.1016/j.trsl.2017.09.004. Epub 2017 Oct 6.

PMID:
29066320
14.

Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells.

Pagotto A, Pilotto G, Mazzoldi EL, Nicoletto MO, Frezzini S, Pastò A, Amadori A.

Cell Death Dis. 2017 Jul 20;8(7):e2943. doi: 10.1038/cddis.2017.327.

15.

Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT).

Russo V, Amadori A, Bregni M, Calabrò L, Colombo MP, Di Nicola M, Ferrucci PF, Proietti E, Maio M, Bellone M.

Cytokine Growth Factor Rev. 2017 Aug;36:1-3. doi: 10.1016/j.cytogfr.2017.06.004. Epub 2017 Jun 16.

PMID:
28634022
16.

Italian COnsensus in Neuroradiological Anesthesia (ICONA).

Castioni CA, Amadori A, Bilotta F, Bolzon M, Barboni E, Caricato A, Dall'acqua G, DI Paola F, Forastieri Molinari A, Gritti P, LA Rosa I, Longo M, Maglione C, Martorano P, Munari M, Perotti V, Rasulo F, Ruggiero M, Santoro A, Scudeller L, Tumolo M, Mazzeo AT; SIAARTI Study Group on Neuroanesthesia and Neuroresuscitation, AINR, SARNePI, SINCh.

Minerva Anestesiol. 2017 Sep;83(9):956-971. doi: 10.23736/S0375-9393.17.11753-0. Epub 2017 May 11.

17.

1st Evidence-based Italian consensus conference on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis from ovarian cancer.

Cavaliere D, Cirocchi R, Coccolini F, Fagotti A, Fambrini M, Federici O, Lorusso D, Vaira M, Ceresoli M, Delrio P, Garofalo A, Pignata S, Scollo P, Trojano V, Amadori A, Ansaloni L, Cariti G, De Cian F, De Iaco P, De Simone M, Deraco M, Donini A, Fiorentini G, Frigerio L, Greggi S, Macrì A, Pasqual EM, Roviello F, Sammartino P, Sassaroli C, Scambia G, Staudacher C, Vici P, Vizza E, Valle M; Italian Society of Surgical Oncology (SICO); Italian Society of Obstetrics and Gynaecology (SIGO); Italian Association of Hospital Obstetricians and Gynaecologists (AOGOI); Italian Association of Medical Oncology (AIOM).

Tumori. 2017 Nov 23;103(6):525-536. doi: 10.5301/tj.5000623. Epub 2017 Apr 20.

PMID:
28430350
18.

Tumor-associated myeloid cells as guiding forces of cancer cell stemness.

Sica A, Porta C, Amadori A, Pastò A.

Cancer Immunol Immunother. 2017 Aug;66(8):1025-1036. doi: 10.1007/s00262-017-1997-8. Epub 2017 Apr 11. Review.

PMID:
28401258
19.

LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab.

Bonanno L, De Paoli A, Zulato E, Esposito G, Calabrese F, Favaretto A, Santo A, Conte AD, Chilosi M, Oniga F, Sozzi G, Moro M, Ciccarese F, Nardo G, Bertorelle R, Candiotto C, De Salvo GL, Amadori A, Conte P, Indraccolo S.

Clin Cancer Res. 2017 Jul 1;23(13):3316-3324. doi: 10.1158/1078-0432.CCR-16-2410. Epub 2017 Jan 24.

20.

Resistance to glucose starvation as metabolic trait of platinum-resistant human epithelial ovarian cancer cells.

Pastò A, Pagotto A, Pilotto G, De Paoli A, De Salvo GL, Baldoni A, Nicoletto MO, Ricci F, Damia G, Bellio C, Indraccolo S, Amadori A.

Oncotarget. 2017 Jan 24;8(4):6433-6445. doi: 10.18632/oncotarget.14118.

21.

Role of Telomerase in Cervical Lesions as Prognostic Marker: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization.

Ravaioli S, Tumedei MM, Amadori A, Puccetti M, Chiadini E, Bravaccini S.

J Low Genit Tract Dis. 2017 Jan;21(1):42-46. doi: 10.1097/LGT.0000000000000261.

PMID:
27611439
22.
23.

Liquid biopsy as a novel tool to monitor the carcinogenesis of Barrett's esophagus.

Boldrin E, Rumiato E, Fassan M, Balsamo L, Realdon S, Battaglia G, Rugge M, Amadori A, Saggioro D.

Transl Res. 2016 Oct;176:127-31. doi: 10.1016/j.trsl.2016.05.001. Epub 2016 May 10.

PMID:
27234667
24.

Predictive role of host constitutive variants in neoadjuvant therapy of esophageal cancer.

Rumiato E, Boldrin E, Amadori A, Saggioro D.

Pharmacogenomics. 2016 May;17(7):805-20. doi: 10.2217/pgs-2016-0009. Epub 2016 May 16. Review.

PMID:
27181132
25.

Morphological and genetic heterogeneity in multifocal lung adenocarcinoma: The case of a never-smoker woman.

Bonanno L, Calabrese F, Nardo G, Calistri D, Tebaldi M, Tedaldi G, Polo V, Vuljan S, Favaretto A, Conte P, Amadori A, Rea F, Indraccolo S.

Lung Cancer. 2016 Jun;96:52-5. doi: 10.1016/j.lungcan.2016.03.009. Epub 2016 Mar 25.

PMID:
27133750
26.

A hypoxic signature marks tumors formed by disseminated tumor cells in the BALB-neuT mammary cancer model.

Msaki A, Pastò A, Curtarello M, Arigoni M, Barutello G, Calogero RA, Macagno M, Cavallo F, Amadori A, Indraccolo S.

Oncotarget. 2016 May 31;7(22):33081-95. doi: 10.18632/oncotarget.8859.

27.

Reconstruction of gene regulatory modules from RNA silencing of IFN-α modulators: experimental set-up and inference method.

Grassi A, Di Camillo B, Ciccarese F, Agnusdei V, Zanovello P, Amadori A, Finesso L, Indraccolo S, Toffolo GM.

BMC Genomics. 2016 Mar 12;17:228. doi: 10.1186/s12864-016-2525-5.

28.

A germline predictive signature of response to platinum chemotherapy in esophageal cancer.

Rumiato E, Boldrin E, Malacrida S, Battaglia G, Bocus P, Castoro C, Cagol M, Chiarion-Sileni V, Ruol A, Amadori A, Saggioro D.

Transl Res. 2016 May;171:29-37.e1. doi: 10.1016/j.trsl.2015.12.011. Epub 2015 Dec 22.

PMID:
26772957
29.

An immediate transcriptional signature associated with response to the histone deacetylase inhibitor Givinostat in T acute lymphoblastic leukemia xenografts.

Pinazza M, Borga C, Agnusdei V, Minuzzo S, Fossati G, Paganin M, Michielotto B, De Paoli A, Basso G, Amadori A, te Kronnie G, Indraccolo S.

Cell Death Dis. 2016 Jan 14;6:e2047. doi: 10.1038/cddis.2015.394.

30.

Calcineurin and GSK-3 inhibition sensitizes T-cell acute lymphoblastic leukemia cells to apoptosis through X-linked inhibitor of apoptosis protein degradation.

Tosello V, Bordin F, Yu J, Agnusdei V, Indraccolo S, Basso G, Amadori A, Piovan E.

Leukemia. 2016 Apr;30(4):812-22. doi: 10.1038/leu.2015.335. Epub 2015 Dec 9.

PMID:
26648536
31.

An experimental study about haptic feedback in robotic surgery: may visual feedback substitute tactile feedback?

Meccariello G, Faedi F, AlGhamdi S, Montevecchi F, Firinu E, Zanotti C, Cavaliere D, Gunelli R, Taurchini M, Amadori A, Vicini C.

J Robot Surg. 2016 Mar;10(1):57-61. doi: 10.1007/s11701-015-0541-0. Epub 2015 Nov 11.

PMID:
26559538
32.

Predictive markers in elderly patients with estrogen receptor-positive breast cancer treated with aromatase inhibitors: an array-based pharmacogenetic study.

Rumiato E, Brunello A, Ahcene-Djaballah S, Borgato L, Gusella M, Menon D, Pasini F, Amadori A, Saggioro D, Zagonel V.

Pharmacogenomics J. 2016 Nov;16(6):525-529. doi: 10.1038/tpj.2015.73. Epub 2015 Oct 27.

PMID:
26503812
33.

Antineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma.

Riva G, Lagreca I, Mattiolo A, Belletti D, Lignitto L, Barozzi P, Ruozi B, Vallerini D, Quadrelli C, Corradini G, Forghieri F, Marasca R, Narni F, Tosi G, Forni F, Vandelli MA, Amadori A, Chieco-Bianchi L, Potenza L, Calabrò ML, Luppi M.

Haematologica. 2015 Nov;100(11):e467-70. doi: 10.3324/haematol.2015.126854. Epub 2015 Jul 23. No abstract available.

34.

Genetic risk of subsequent esophageal cancer in lymphoma and breast cancer long-term survival patients: a pilot study.

Boldrin E, Rumiato E, Fassan M, Rugge M, Cagol M, Marino D, Chiarion-Sileni V, Ruol A, Gusella M, Pasini F, Amadori A, Saggioro D.

Pharmacogenomics J. 2016 Jun;16(3):266-71. doi: 10.1038/tpj.2015.41. Epub 2015 Jun 9.

PMID:
26054330
35.

Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?

Brandes AA, Franceschi E, Ermani M, Tosoni A, Albani F, Depenni R, Faedi M, Pisanello A, Crisi G, Urbini B, Dazzi C, Cavanna L, Mucciarini C, Pasini G, Bartolini S, Marucci G, Morandi L, Zunarelli E, Cerasoli S, Gardini G, Lanza G, Silini EM, Cavuto S, Baruzzi A, Baruzzi A, Albani F, Calbucci F, D'Alessandro R, Michelucci R, Brandes A, Eusebi V, Ceruti S, Fainardi E, Tamarozzi R, Emiliani E, Cavallo M, Franceschi E, Tosoni A, Cavallo M, Fiorica F, Valentini A, Depenni R, Mucciarini C, Crisi G, Sasso E, Biasini C, Cavanna L, Guidetti D, Marcello N, Pisanello A, Cremonini AM, Guiducci G, de Pasqua S, Testoni S, Agati R, Ambrosetto G, Bacci A, Baldin E, Baldrati A, Barbieri E, Bartolini S, Bellavista E, Bisulli F, Bonora E, Bunkheila F, Carelli V, Crisci M, Dall'Occa P, de Biase D, Ferro S, Franceschi C, Frezza G, Grasso V, Leonardi M, Marucci G, Mazzocchi V, Morandi L, Mostacci B, Palandri G, Pasini E, Pastore Trossello M, Pession A, Ragazzi M, Riguzzi P, Rinaldi R, Rizzi S, Romeo G, Spagnolli F, Tinuper P, Trocino C, Cerasoli S, Dall'Agata M, Faedi M, Frattarelli M, Gentili G, Giovannini A, Iorio P, Pasquini U, Galletti G, Guidi C, Neri W, Patuelli A, Strumia S, Casmiro M, Gamboni A, Rasi F, Cruciani G, Cenni P, Dazzi C, Guidi A, Zumaglini F, Amadori A, Pasini G, Pasquinelli M, Pasquini E, Polselli A, Ravasio A, Viti B, Sintini M, Ariatti A, Bertolini F, Bigliardi G, Carpeggiani P, Cavalleri F, Meletti S, Nichelli P, Pettorelli E, Pinna G, Zunarelli E, Artioli F, Bernardini I, Costa M, Greco G, Guerzoni R, Stucchi C, Iaccarino C, Rizzi R, Zuccoli G, Api P, Cartei F, Fallica E, Granieri E, Latini F, Lelli G, Monetti C, Ramponi V, Saletti A, Schivalocchi R, Seraceni S, Tola MR, Urbini B, Giorgi C, Montanari E, Cerasti D, Crafa P, Dascola I, Florindo I, Mazza S, Servadei F, Silini E, Torelli P, Immovilli P, Morelli N, Vanzo C.

Neurooncol Pract. 2014 Dec;1(4):166-171. Epub 2014 Aug 28.

36.

The deregulated expression of miR-125b in acute myeloid leukemia is dependent on the transcription factor C/EBPα.

Vargas Romero P, Cialfi S, Palermo R, De Blasio C, Checquolo S, Bellavia D, Chiaretti S, Foà R, Amadori A, Gulino A, Zardo G, Talora C, Screpanti I.

Leukemia. 2015 Dec;29(12):2442-5. doi: 10.1038/leu.2015.117. Epub 2015 May 18. No abstract available.

37.

An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers.

Blein S, Bardel C, Danjean V, McGuffog L, Healey S, Barrowdale D, Lee A, Dennis J, Kuchenbaecker KB, Soucy P, Terry MB, Chung WK, Goldgar DE, Buys SS; Breast Cancer Family Registry, Janavicius R, Tihomirova L, Tung N, Dorfling CM, van Rensburg EJ, Neuhausen SL, Ding YC, Gerdes AM, Ejlertsen B, Nielsen FC, Hansen TV, Osorio A, Benitez J, Conejero RA, Segota E, Weitzel JN, Thelander M, Peterlongo P, Radice P, Pensotti V, Dolcetti R, Bonanni B, Peissel B, Zaffaroni D, Scuvera G, Manoukian S, Varesco L, Capone GL, Papi L, Ottini L, Yannoukakos D, Konstantopoulou I, Garber J, Hamann U, Donaldson A, Brady A, Brewer C, Foo C, Evans DG, Frost D, Eccles D; EMBRACE, Douglas F, Cook J, Adlard J, Barwell J, Walker L, Izatt L, Side LE, Kennedy MJ, Tischkowitz M, Rogers MT, Porteous ME, Morrison PJ, Platte R, Eeles R, Davidson R, Hodgson S, Cole T, Godwin AK, Isaacs C, Claes K, De Leeneer K, Meindl A, Gehrig A, Wappenschmidt B, Sutter C, Engel C, Niederacher D, Steinemann D, Plendl H, Kast K, Rhiem K, Ditsch N, Arnold N, Varon-Mateeva R, Schmutzler RK, Preisler-Adams S, Markov NB, Wang-Gohrke S, de Pauw A, Lefol C, Lasset C, Leroux D, Rouleau E, Damiola F; GEMO Study Collaborators, Dreyfus H, Barjhoux L, Golmard L, Uhrhammer N, Bonadona V, Sornin V, Bignon YJ, Carter J, Van Le L, Piedmonte M, DiSilvestro PA, de la Hoya M, Caldes T, Nevanlinna H, Aittomäki K, Jager A, van den Ouweland AM, Kets CM, Aalfs CM, van Leeuwen FE, Hogervorst FB, Meijers-Heijboer HE; HEBON, Oosterwijk JC, van Roozendaal KE, Rookus MA, Devilee P, van der Luijt RB, Olah E, Diez O, Teulé A, Lazaro C, Blanco I, Del Valle J, Jakubowska A, Sukiennicki G, Gronwald J, Lubinski J, Durda K, Jaworska-Bieniek K, Agnarsson BA, Maugard C, Amadori A, Montagna M, Teixeira MR, Spurdle AB, Foulkes W, Olswold C, Lindor NM, Pankratz VS, Szabo CI, Lincoln A, Jacobs L, Corines M, Robson M, Vijai J, Berger A, Fink-Retter A, Singer CF, Rappaport C, Kaulich DG, Pfeiler G, Tea MK, Greene MH, Mai PL, Rennert G, Imyanitov EN, Mulligan AM, Glendon G, Andrulis IL, Tchatchou S, Toland AE, Pedersen IS, Thomassen M, Kruse TA, Jensen UB, Caligo MA, Friedman E, Zidan J, Laitman Y, Lindblom A, Melin B, Arver B, Loman N, Rosenquist R, Olopade OI, Nussbaum RL, Ramus SJ, Nathanson KL, Domchek SM, Rebbeck TR, Arun BK, Mitchell G, Karlan BY, Lester J, Orsulic S, Stoppa-Lyonnet D, Thomas G, Simard J, Couch FJ, Offit K, Easton DF, Chenevix-Trench G, Antoniou AC, Mazoyer S, Phelan CM, Sinilnikova OM, Cox DG.

Breast Cancer Res. 2015 Apr 25;17:61. doi: 10.1186/s13058-015-0567-2.

38.

Genetic features of metachronous esophageal cancer developed in Hodgkin's lymphoma or breast cancer long-term survivors: an exploratory study.

Boldrin E, Rumiato E, Fassan M, Cappellesso R, Rugge M, Chiarion-Sileni V, Ruol A, Alfieri R, Cagol M, Castoro C, Amadori A, Saggioro D.

PLoS One. 2015 Jan 22;10(1):e0117070. doi: 10.1371/journal.pone.0117070. eCollection 2015. Erratum in: PLoS One. 2015;10(3):e0121467.

39.

Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients.

Rossi E, Rugge M, Facchinetti A, Pizzi M, Nardo G, Barbieri V, Manicone M, De Faveri S, Chiara Scaini M, Basso U, Amadori A, Zamarchi R.

Oncoscience. 2013 Dec 31;1(1):49-56. eCollection 2014.

40.

VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells.

Curtarello M, Zulato E, Nardo G, Valtorta S, Guzzo G, Rossi E, Esposito G, Msaki A, Pastò A, Rasola A, Persano L, Ciccarese F, Bertorelle R, Todde S, Plebani M, Schroer H, Walenta S, Mueller-Klieser W, Amadori A, Moresco RM, Indraccolo S.

Cancer Res. 2015 Jan 1;75(1):120-33. doi: 10.1158/0008-5472.CAN-13-2037. Epub 2014 Nov 7.

41.

DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.

Minuzzo S, Agnusdei V, Pusceddu I, Pinazza M, Moserle L, Masiero M, Rossi E, Crescenzi M, Hoey T, Ponzoni M, Amadori A, Indraccolo S.

Carcinogenesis. 2015 Jan;36(1):115-21. doi: 10.1093/carcin/bgu223. Epub 2014 Oct 29.

PMID:
25355291
42.

Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation.

Pastò A, Bellio C, Pilotto G, Ciminale V, Silic-Benussi M, Guzzo G, Rasola A, Frasson C, Nardo G, Zulato E, Nicoletto MO, Manicone M, Indraccolo S, Amadori A.

Oncotarget. 2014 Jun 30;5(12):4305-19.

43.

Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia.

Kumar V, Palermo R, Talora C, Campese AF, Checquolo S, Bellavia D, Tottone L, Testa G, Miele E, Indraccolo S, Amadori A, Ferretti E, Gulino A, Vacca A, Screpanti I.

Leukemia. 2014 Dec;28(12):2324-35. doi: 10.1038/leu.2014.133. Epub 2014 Apr 14.

PMID:
24727676
44.

NOTCH3 signaling regulates MUSASHI-1 expression in metastatic colorectal cancer cells.

Pastò A, Serafin V, Pilotto G, Lago C, Bellio C, Trusolino L, Bertotti A, Hoey T, Plateroti M, Esposito G, Pinazza M, Agostini M, Nitti D, Amadori A, Indraccolo S.

Cancer Res. 2014 Apr 1;74(7):2106-18. doi: 10.1158/0008-5472.CAN-13-2022. Epub 2014 Feb 13.

45.

Accreditation for excellence of cancer research institutes: recommendations from the Italian Network of Comprehensive Cancer Centers.

Deriu PL, La Pietra L, Pierotti M, Collazzo R, Paradiso A, Belardelli F, De Paoli P, Nigro A, Lacalamita R, Ferrarini M, Pelicci P, Pierotti M, Roli A, Ciliberto G, Scala S, Amadori A, Chiusole D, Musto P, Fusco V, Storto G, De Maria R, Canitano S, Apolone G, Ravelli M, Mazzini E, Amadori D, Bernabini M, Ancarani V, Lombardo C.

Tumori. 2013 Nov-Dec;99(6):293e-8e. doi: 10.1700/1390.15472.

46.

Interferon beta 1a anaphylaxis, a case report. Standardization of non-irritating concentration for allergy skin tests.

Cortellini G, Amadori A, Comandini T, Corvetta A.

Eur Ann Allergy Clin Immunol. 2013 Sep 1;45(5):181-2.

PMID:
24129047
47.

Clinical and Genetic Factors Associated With Severe Hematological Toxicity in Glioblastoma Patients During Radiation Plus Temozolomide Treatment: A Prospective Study.

Lombardi G, Rumiato E, Bertorelle R, Saggioro D, Farina P, Della Puppa A, Zustovich F, Berti F, Sacchetto V, Marcato R, Amadori A, Zagonel V.

Am J Clin Oncol. 2015 Oct;38(5):514-9. doi: 10.1097/COC.0b013e3182a790ea.

PMID:
24064758
48.

ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy.

Rumiato E, Cavallin F, Boldrin E, Cagol M, Alfieri R, Basso D, Castoro C, Ancona E, Amadori A, Ruol A, Saggioro D.

Pharmacogenet Genomics. 2013 Nov;23(11):597-604. doi: 10.1097/FPC.0b013e3283653afc.

PMID:
23962907
49.

Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts.

Agnusdei V, Minuzzo S, Frasson C, Grassi A, Axelrod F, Satyal S, Gurney A, Hoey T, Seganfreddo E, Basso G, Valtorta S, Moresco RM, Amadori A, Indraccolo S.

Leukemia. 2014 Feb;28(2):278-88. doi: 10.1038/leu.2013.183. Epub 2013 Jun 18.

PMID:
23774673
50.

DMET™ (Drug-Metabolizing Enzymes and Transporters) microarray analysis of colorectal cancer patients with severe 5-fluorouracil-induced toxicity.

Rumiato E, Boldrin E, Amadori A, Saggioro D.

Cancer Chemother Pharmacol. 2013 Aug;72(2):483-8. doi: 10.1007/s00280-013-2210-1. Epub 2013 Jun 13.

PMID:
23760813

Supplemental Content

Loading ...
Support Center